Enterprise Value
28.56M
Cash
13.02M
Avg Qtr Burn
-5.955M
Short % of Float
2.05%
Insider Ownership
22.86%
Institutional Own.
39.88%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
INB-400 Details Glioblastoma, Cancer | Phase 2 Data readout | |
INB-100 Details Leukemia, Cancer, Blood cancer | Phase 1 Data readout | |
INB-200 Details Glioblastoma | Phase 1 Data readout |